At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 78 enrolled
Drug / intervention
Prepopik® ½ Sachet x 2 (9-12 years) +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Assessor-Blind, Multicenter, Dose-Ranging Study Comparing the Safety and Efficacy of Prepopik® Versus Polyethylene Glycol Preparation (Local Standard of Care) in Children Aged 9 Years to 16 Years
In Brief
A Phase 2 clinical trial evaluating Prepopik® ½ Sachet x 2 (9-12 years), Prepopik® 1 Sachet x 2 (9-12 years), and 3 other interventions for Need for Bowel Preparation. Completed, enrolled 78 participants across 9 sites.
Detailed Summary
To study the efficacy and safety of Prepopik® in children aged 9 to 16 years for overall colon cleansing in preparation of colonoscopy
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeed for Bowel Preparation
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedAug 2013
Enrollment StartJun 2014
Primary CompletionFeb 2017
Study CompletionMar 2017
TodayJul 2026
First PostedAug 27, 2013
Enrollment StartJun 3, 2014
Primary CompletionFeb 15, 2017
Study CompletionMar 16, 2017
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 12.8 years ago
Interventions
Prepopik® ½ Sachet x 2 (9-12 years)drug
Prepopik® 1 Sachet x 2 (9-12 years)drug
Oral polyethylene glycol (PEG) based preparation (9-12 years)drug
Prepopik® 1 Sachet x 2 (13-16 years)drug
Oral polyethylene glycol (PEG) based preparation (13-16 years)drug